To the Editor: Lichen planopilaris (LPP) is a variant of lichen planus characterized by follicular hyperkeratosis and T-lymphocyte mediated perifollicular inflammation that often progresses to irreversible, scarring alopecia. There is a paucity of epidemiological data on LPP, with current estimates of LPP prevalence being based on single-center and single-city studies.1, 2, 3, 4 There are no studies that evaluate LPP prevalence in a diverse, nationwide cohort of American patients. Here, we aimed to estimate the prevalence of LPP using the All of Us database, a recently launched initiative by the National Institutes of Health that strives to include communities that have been historically underrepresented in research.We performed a cross-sectional analysis in All of Us and identified LPP cases using International Classification of Diseases, Tenth Revision, Clinical Modification code L66.1 and SNOMED code 64540004. Participants’ age, ethnicity, race, and sex were extracted from electronic medical records. The overall prevalence and prevalence within each age and racial/ethnic group were calculated using the Wald method with 95% CIs.As of March 2022, All of Us has enrolled 327,654 participants. We identified 142 individuals with LPP, representing an overall prevalence of 0.043% (95% CI, 0.042-0.044). The average age at diagnosis was 62.4 years (SD, 11.2 years). The prevalence was highest in the 65-74 year age group (0.091%; 95% CI, 0.088-0.093), followed by the 55 to 64 year age group (0.054%; 95% CI, 0.052-0.055). Females constituted 91.6% of the LPP population. Prevalence in specific racial groups included 0.009% (95% CI, 0.007-0.011) in Asian, 0.029% (95% CI, 0.028-0.030) in Black, 0.021% (95% CI, 0.020-0.023) in Hispanic, and 0.057% (95% CI, 0.019-0.021) in White participants (Table I). Altogether, the majority of LPP cases were over the age of 55 years and self-identified as White (Fig 1).
Table I
Prevalence of lichen planopilaris in All of Us across age and racial/ethnic groups
Group
Total population, n
LPP cases, n
Prevalence, % (95% CI)
Female, n (%)
Overall
327,654
142
0.043 (0.042-0.044)
129 (91.6)
Age group, y
<45
111,618
9
0.008 (0.008-0.009)
7 (77.8)
45-54
51,047
23
0.045 (0.043-0.047)
21 (91.3)
55-64
69,141
37
0.054 (0.052-0.055)
32 (86.5)
65-74
64,072
58
0.091 (0.088-0.093)
53 (91.4)
74+
36,480
15
0.041 (0.039-0.043)
15 (100.0)
Racial/ethnic group
Asian
11,040
1
0.009 (0.007-0.011)
0 (0)
Black
69,087
20
0.029 (0.028-0.030)
18 (90.0)
Hispanic
60,540
12
0.020 (0.019-0.021)
12 (100.0)
White
177,647
101
0.057 (0.056-0.058)
93 (92.1)
LPP, Lichen planopilaris.
Fig 1
Distribution of lichen planopilaris cases by age group.
Prevalence of lichen planopilaris in All of Us across age and racial/ethnic groupsLPP, Lichen planopilaris.Distribution of lichen planopilaris cases by age group.We show that LPP is most prevalent in women over the age of 55 years, a finding consistent with previous studies.2, 3, 4 In addition, we note LPP to be most prevalent among Whites, supporting the study by Trager et al. However, our prevalence estimate of 0.043% is higher than the 0.017% prevalence reported by Trager et al.Our analysis is subject to limitations. We base our identification of LPP cases on billing codes and are unable to confirm the diagnosis of LPP via histopathology reports. Additionally, older adults are overrepresented in All of Us, skewing the age distribution toward the 55 to 64 and 65 to 75 year age groups. Moreover, the diagnosis of hair disorders (in comparison to skin diseases) is often delayed, affecting the age at which diagnosis is thought to be most prevalent. Hair disorders may also be underdiagnosed in patients with skin of color; thus, the actual prevalence of LPP in patients with skin of color may be higher than the estimates we provide. Additional studies utilizing a national registry or a large insurance claims database would be helpful in further characterizing LPP prevalence in the United States.
Authors: Megan H Trager; Jonathan Lavian; Eunice Y Lee; Dahsan Gary; Fabian Jenkins; Angela M Christiano; Lindsey A Bordone Journal: J Am Acad Dermatol Date: 2020-10-31 Impact factor: 11.527
Authors: Joshua C Denny; Joni L Rutter; David B Goldstein; Anthony Philippakis; Jordan W Smoller; Gwynne Jenkins; Eric Dishman Journal: N Engl J Med Date: 2019-08-15 Impact factor: 176.079